49
Xu J, Cao B*. Appropriate use of antimicrobials in primary healthcare facility: a long way to go. Clinical Microbiology and Infection. 2023;29(5):563-4. doi: 10.1016/j.cmi.2023.02.010.
50
Wu X#, Xuan W#, Yang X, Liu W, Zhang H, Jiang G, Cao B*, Jiang Y*. Ficolin A knockout alleviates sepsis-induced severe lung injury in mice by restoring gut Akkermansia to inhibit S100A4/STAT3 pathway. International immunopharmacology. 2023;121:110548-. doi: 10.1016/j.intimp.2023.110548.
51
Shang L, Cao B*. Adapted vaccine strategy: facing the persistent challenges of COVID-19. The Lancet Infectious diseases. 2023. doi: 10.1016/s1473-3099(23)00370-5.
52
Pu D#, Zhao J#, Lu B, Zhang Y, Wu Y, Li Z, Zhuo X, Cao B*. Within-host resistance evolution of a fatal ST11 hypervirulent carbapenem-resistant Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 2023;61(4). doi: 10.1016/j.ijantimicag.2023.106747.
53
Mu S#, Zou X#, Wang Y#, Deng X, Cui D, Liu S, Cao B*. The combined effect of oseltamivir and favipiravir on influenza A virus evolution in patients hospitalized with severe influenza. Antiviral research. 2023;216:105657-. doi: 10.1016/j.antiviral.2023.105657.
54
Liu Y#, Xu J#, Wang C, Lu B, Liang C, Hou G, Cui X, Cao B*. Pulmonary Mucormycosis with Rib Involvement in an Immunocompromised Patient. American Journal of Respiratory and Critical Care Medicine. 2023;207(10):1393-4. doi: 10.1164/rccm.202207-1290IM.
55
Jia J#, Li H, Huang Z, Yu J, Zheng Y, Cao B*. Comprehensive immune landscape of lung-resident memory CD8(+) T cells after influenza infection and reinfection in a mouse model. Frontiers in Microbiology. 2023;14. doi: 10.3389/fmicb.2023.1184884.
56
Huang C#, Huang L#, Wang Y#, Li X#, Ren L#, Gu X#, Kang L#, Guo L#, Liu M#, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J*, Zhang D*, Cao B*. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England). 2023;401(10393):e21-e33. doi: 10.1016/s0140-6736(23)00810-3.
57
Du S#, Shang L, Zou X, Deng X, Sun A, Mu S, Zhao J, Wang Y, Feng X, Li B, Wang C, Liu S, Lu B, Liu Y, Zhang R, Tong Y, Cao B*. Azithromycin Exposure Induces Transient Microbial Composition Shifts and Decreases the Airway Microbiota Resilience from Outdoor PM2.5 Stress in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled Trial. Microbiology Spectrum. 2023. doi: 10.1128/spectrum.02066-22.
58
Guo L#, Zhang Q, Zhang C, Huang T, Ren L, Cao B*, Wang J*. Assessment of Antibody and T-Cell Responses to the SARS-CoV-2 Virus and Omicron Variant in Unvaccinated Individuals Recovered From COVID-19 Infection in Wuhan, China. JAMA Netw Open. 2022 Apr 1;5(4):e229199. doi: 10.1001/jamanetworkopen.2022.9199.
59
Zhao J#, Li Z#, Zhang Y, Liu X, Lu B*, Cao B*. Convergence of MCR-8.2 and Chromosome-Mediated Resistance to Colistin and Tigecycline in an NDM-5-Producing ST656 Klebsiella pneumoniae Isolate From a Lung Transplant Patient in China. Front Cell Infect Microbiol. 2022 Jul 11;12:922031. doi: 10.3389/fcimb.2022.922031. eCollection 2022.
60
Shang L#, Cao B*. Protein-based vaccine as the booster dose for adults: evidence and beyond. Lancet Infect Dis. 2022 Aug 10. pii: S1473-3099(22)00447-9. doi: 10.1016/S1473-3099(22)00447-9.
61
Yang X#, Hou C, Shen Y, Zhang M, Zhang K, Wang F, Liu Y, Ma X, Cheng L, Kang J, Hu B, Wang M, Zeng L, Wang Y, He Y, Cao G, Jiang J, Jones P, Cao B*, Li L*. Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China. JAMA Netw Open. 2022 Sep 1;5(9):e2231790. doi: 10.1001/jamanetworkopen.2022.31790.
62
Zhang H#, Cao B*. Post-infection rehabilitation of COVID-19 patients: Findings and prospects. Lancet Reg Health Eur. 2022 Nov;22:100496. doi: 10.1016/j.lanepe.2022.100496. Epub 2022 Sep 1.
63
Wang Z#, Deng T#, Zhang Y#, Niu W, Nie Q, Yang S, Liu P, Pei P, Chen L, Li H*, Cao B*. ACE2 can act as the secondary receptor in the FcgammaR-dependent ADE of SARS-CoV-2 infection. iScience. 2022 Jan 21;25(1):103720. doi: 10.1016/j.isci.2021.103720. Epub 2021 Dec 31.
64
Cui D#, Chen S#, Feng L#, Jia M#, Wang Y#, Xiao W, Sun Y, Huang Q, Ma L, Leng Z, Wang H, Cao B*, Yang W*, Yang J*, Wang C*.Long-term outcomes in COVID-19 patients who recovered from the first wave of the pandemic.Natl Sci Rev. 2022 Sep 20;9(11):nwac192. doi: 10.1093/nsr/nwac192. eCollection 2022 Nov.
